Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Zynex
(NASDAQ:ZYXI)
Intraday
$11.26
0.12
[1.08%]
After-Hours
$11.26
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$11.26
0.12
[1.08%]
At close: Apr 23
$11.26
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 7 days from now on Tue Apr 30th, after the market close
Conference call scheduled in 7 days at 16:15 PM
Click to view the webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Zynex Stock (NASDAQ:ZYXI)
Zynex Stock (NASDAQ: ZYXI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, March 01, 2024
RBC Capital Maintains Outperform on Zynex, Raises Price Target to $15
Benzinga Newsdesk
-
Mar 1, 2024, 10:52AM
HC Wainwright & Co. Maintains Buy on Zynex, Raises Price Target to $21
Benzinga Newsdesk
-
Mar 1, 2024, 7:09AM
Thursday, February 29, 2024
Zynex shares are trading lower after the company reported worse-than-expected Q4 financial results and issued guidance.
Benzinga Newsdesk
-
Feb 29, 2024, 4:45PM
Zynex Company Announces Additional $20 Million Stock Repurchase Plan
Benzinga Newsdesk
-
Feb 29, 2024, 4:35PM
Zynex Sees Q1 EPS $0.03+ vs $0.04 Est., Revenue $47.5M+ vs $47.74M Est.; Sees FY24 EPS $0.50+ vs $0.54 Est., Net Revenue $227M+ vs $232.85M Est.
Benzinga Newsdesk
-
Feb 29, 2024, 4:34PM
Zynex: Q4 Earnings Insights
Benzinga Insights
-
Feb 29, 2024, 4:05PM
Zynex Q4 2023 GAAP EPS $0.040 Misses $0.170 Estimate, Sales $47.284M Miss $54.527M Estimate
Benzinga Newsdesk
-
Feb 29, 2024, 4:03PM
Earnings Scheduled For February 29, 2024
Benzinga Insights
-
Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Earnings Preview: Zynex
Benzinga Insights
-
Feb 28, 2024, 12:01PM
Tuesday, February 20, 2024
Zynex Introduces New Products: The Zynex Pro Hybrid LSO And The Zynex DynaComp Cold Compression
Benzinga Newsdesk
-
Feb 20, 2024, 9:22AM
Tuesday, February 06, 2024
Zynex Receives FDA Clearance For Its M-Wave Neuromuscular Electrical Stimulation Device
Benzinga Newsdesk
-
Feb 6, 2024, 9:16AM
Monday, November 13, 2023
Zynex Submits FDA Application For Its Next Generation NMES Device
Benzinga Newsdesk
-
Nov 13, 2023, 9:19AM
Wednesday, November 01, 2023
EXCLUSIVE: Medical Devices Firm Zynex Launches New $20M Share Repurchase Program
Vandana Singh
-
Nov 1, 2023, 8:30AM
EXCLUSIVE: Zynex Tells Benzinga Co.'s Board Of Directors Has Approved A Program To Repurchase Up To $20M Of The Company's Common Stock
Benzinga Newsdesk
-
Nov 1, 2023, 8:30AM
AMD, Yum China, Paycom Software And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin
-
Nov 1, 2023, 6:17AM
Tuesday, October 31, 2023
Zynex Announces Review Of Strategic Alternatives
Benzinga Newsdesk
-
Oct 31, 2023, 7:59AM
Monday, October 30, 2023
Bloomberg Reported Zynex Weighing Strategic Options Including Possible Sale
Charles Gross
-
Oct 30, 2023, 6:02PM
Friday, October 27, 2023
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Oct 27, 2023, 1:30PM
Zynex shares are trading higher after the company reported better-than-expected Q3 financial results.
Benzinga Newsdesk
-
Oct 27, 2023, 12:23PM
Thursday, October 26, 2023
Zynex Q3 EPS $0.10 Beats $0.09 Estimate, Sales $49.91M Beat $49.87M Estimate
Benzinga Newsdesk
-
Oct 26, 2023, 4:38PM
Earnings Scheduled For October 26, 2023
Benzinga Insights
-
Oct 26, 2023, 7:20AM
Monday, October 16, 2023
Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023
Benzinga Insights
-
Oct 16, 2023, 11:00AM
RBC Capital Initiates Coverage On Zynex with Outperform Rating, Announces Price Target of $13
Benzinga Newsdesk
-
Oct 16, 2023, 8:19AM
Monday, September 11, 2023
Zynex Announces $10M Share Repurchase Program Effective Sept. 13 Through Sept. 12, 2024
Benzinga Newsdesk
-
Sep 11, 2023, 9:17AM
Thursday, September 07, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Sep 7, 2023, 1:55PM
Tuesday, September 05, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Sep 5, 2023, 1:34PM
Monday, August 14, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
-
Aug 14, 2023, 1:48PM
Friday, August 11, 2023
Innovative New Technology Is Driving This Startup's Early Success
Johnny Rice
-
Aug 11, 2023, 10:09AM
Thursday, August 10, 2023
Zynex Announces Co Has Treated More Than 1M Patients Through Its Pain Management Division
Happy Mohamed
-
Aug 10, 2023, 9:20AM
Wednesday, August 09, 2023
Zynex, Inc Announces New Therapy Products Centered Around Pain Management. The New Products Include Zynex Pro Thoracic Lumbar Sacral Orthosis, Zynex Pro Wrist And Zynex Cryoheat
Benzinga Newsdesk
-
Aug 9, 2023, 9:18AM
Tuesday, August 08, 2023
Chief Operating Officer of Zynex Makes $100K Sale
Benzinga Insights
-
Aug 8, 2023, 11:02AM
Zynex Recent Insider Activity
Benzinga Insights
-
Aug 8, 2023, 11:02AM
Monday, August 07, 2023
Many Obstacles Stand In The Way Of Bio Pharma - Zynex Chef Shares His Vision For Success
Johnny Rice
-
Aug 7, 2023, 10:24AM
Thursday, July 27, 2023
Zynex Q2 EPS $0.09 Beats $0.04 Estimate, Sales $44.95M Beat $44.65M Estimate
Benzinga Newsdesk
-
Jul 27, 2023, 4:32PM
Earnings Scheduled For July 27, 2023
Benzinga Insights
-
Jul 27, 2023, 4:34AM
Wednesday, July 26, 2023
Earnings Preview For Zynex
Benzinga Insights
-
Jul 26, 2023, 3:01PM
Wednesday, July 12, 2023
Zynex Sees FY23 Guidance EPS $0.40-$0.50 Vs $0.45 Est; Revenue $180M-$200M Vs $192.68M Est
Benzinga Newsdesk
-
Jul 12, 2023, 9:20AM
Zynex Reports Preliminary Q2 EPS $0.03-$0.07; Revenue $43.5M-$45.5M Up 21% YoY
Benzinga Newsdesk
-
Jul 12, 2023, 9:18AM
Tuesday, June 20, 2023
Zynex Receives FDA Clearance Of CM-1600 Monitor For Improved Blood And Fluid Management
Happy Mohamed
-
Jun 20, 2023, 9:15AM
Friday, June 16, 2023
Zynex President Trades Company's Stock
Benzinga Insights
-
Jun 16, 2023, 11:08AM
Wednesday, June 14, 2023
Zynex shares are trading higher after the company announced a $10 million buyback program.
Benzinga Newsdesk
-
Jun 14, 2023, 1:42PM
Zynex Plans New $10M Stock Buyback Program
Lekha Gupta
-
Jun 14, 2023, 12:24PM
Zynex Announces $10M Share Buyback Program
Benzinga Newsdesk
-
Jun 14, 2023, 9:15AM
Friday, May 05, 2023
Zynex Priced Private Offering Of $52.5M 5.00% Convertible Senior Notes Due 2026. The Notes Offering Was Upsized From The Previously Announced Offering Size Of $50M
Benzinga Newsdesk
-
May 5, 2023, 4:09AM
Thursday, May 04, 2023
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
May 4, 2023, 3:03PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
May 4, 2023, 1:32PM
Zynex shares are trading lower after the company announced a proposed $50 million offering of convertible senior notes and a proposed secondary offering of common stock.
Benzinga Newsdesk
-
May 4, 2023, 9:23AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
May 4, 2023, 9:06AM
Wednesday, May 03, 2023
Zynex Earnings Perspective: Return On Capital Employed
Benzinga Insights
-
May 3, 2023, 10:51AM
Monday, May 01, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
May 1, 2023, 1:31PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch